MYH7
Non syndromic associated CHDs overview

ASD (4, 25%)
Ebstein's malformation of tricuspid valve (12, 75%)
[edit] Synopsis
The structural MYH7 gene encodes the beta myosin heavy chain. Cardiac muscle myosin, along with actin, is one of the major components the contractile system of cardiac muscle (sarcomere). Myosin is a hexamer consisting of two heavy chain subunits (alpha and beta), two light chain subunits and two regulatory subunits. The subfragment-1 (S1) of MYH7 contains an ATPase site and an actin binding region, which are crucial for the movement of actin relative to myosin. The beta myosin heavy chain is expressed predominantly in fetal life and is switched on in older animals under conditions of thyroid hormone depletion/replacement and in response to some physical stresses (Krenz M et al., 2004, Hang CT et al., 2010). This shift in the MHC composition of the cardiac muscle can influence cardiac function (Miyata S et al., 2000). A cardiac-specific microRNA (miR-208) encoded by an intron of the MYH6 gene, is required for cardiomyocyte hypertrophy, fibrosis, and expression of βMHC in response to stress and hypothyroidism (Van Rooij E et al, 2007).
[edit] Mutation studies
Mutations in MYH7 are a common cause for hypertrophic cardiomyopathy (OMIM:192600) and are well recognized in dilated cardiomyopathy and left ventricle non-compaction (LVNC) (Anan R et al., 1994). Mutations in MYH7 are distributed throughout the molecule, and the relationship between mutation location, cardiomyopathy type, and disease severity is poorly understood.
External references for MYH7
Known phenotypes for MYH7
Non-syndromic
Add another phenotype.
Syndromic
Add another phenotype.
Protein interaction partners
Patients reports for MYH7
Translocations
| Region |
References |
OMIM |
Comments
|
Add another translocation.
Mutations in MYH7
| Mutation (DNA)
|
Mutation (peptide)
|
CHD
|
Reference
|
Other features
|
Inheritence
|
Additional info.
|
|
p.1220delQ
|
Ebstein's malformation of tricuspid valve
|
PMID:21127202
|
Ebstein, LVNC (proband AO)
|
Dominant Sporadic
|
 show  hide
| Genetic evidence
|
This variant was inherited from an unaffected parent. This variant was not found in 490 ethnically matched controls.
|
| in silico prediction
|
|
| Functional studies
|
No functional studies were performed for this variant.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
|
p.1459K>N
|
Ebstein's malformation of tricuspid valve
|
PMID:21127202
|
Ebstein (proband AD)
|
Dominant Sporadic
|
 show  hide
| Genetic evidence
|
This variant was inherited from an unaffected parent. This variant was not found in 490 ethnically matched controls.
|
| in silico prediction
|
All identified missense mutations affect amino acids with high degrees of conservation throughout evolution, underscoring the functional importance of these residues.
|
| Functional studies
|
No functional studies were performed for this variant.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
|
p.1573Q>K
|
Ebstein's malformation of tricuspid valve
|
PMID:21127202
|
Ebstein, VSD (kindred 109.787)
|
Dominant Sporadic
|
 show  hide
| Genetic evidence
|
This variant was inherited from an unaffected father. This variant was not found in 490 ethnically matched controls.
|
| in silico prediction
|
All identified missense mutations affect amino acids with high degrees of conservation throughout evolution, underscoring the functional importance of these residues.
|
| Functional studies
|
This variant was inherited from an unaffected father.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
|
p.1918N>K
|
Ebstein's malformation of tricuspid valve
|
PMID:21127202
|
Ebstein, LVNC (kindred 110.240)
|
Dominant Familial
|
 show  hide
| Genetic evidence
|
Segregating : The proband's son presented with bicuspid aortic valve, aortic coarctation, and LVNC. The proband’s asymptomatic brother had LVNC and LV dilatation with LV dysfunction; the proband's mother was also found to have LVNC. All affected family members carried the mutation. This variant was not found in 490 ethnically matched controls.
|
| in silico prediction
|
All identified missense mutations affect amino acids with high degrees of conservation throughout evolution, underscoring the functional importance of these residues.
|
| Functional studies
|
No functional studies were performed for this variant.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
c.842G>C
|
p.281R>T
|
Ebstein's malformation of tricuspid valve
|
PMID:18159245
|
Non-compaction of the ventricular myocardium with Ebstein's anomaly and/or ASD
|
Dominant Familial
|
 show  hide
| Genetic evidence
|
Segregating The mutation was exclusively present in morphologically affected family members. This variant was not detected in 184 normal controls.
|
| in silico prediction
|
The p.281R>T missense mutation is located in the globular head of MHC-beta and affects a position in the vicinity of the switch I loop of the ATPase. The mutation affects a highly conserved amino acid in the myosin subfragment-1 (R281T). In silico simulations suggest that the mutation R281T prevents the formation of a salt bridge between residues R281 and D325, thereby destabilizing the myosin head (Budde BS et al., 2007).
|
| Functional studies
|
No functional studies were performed for this variant.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
|
p.283Y>D
|
Ebstein's malformation of tricuspid valve
|
PMID:21127202
|
Ebstein, LVNC (kindred 16875)
|
Dominant Familial
|
 show  hide
| Genetic evidence
|
Segregating : This variant was inherited from a father with LVNC. This variant was not found in 490 ethnically matched controls.
|
| in silico prediction
|
All identified missense mutations affect amino acids with high degrees of conservation throughout evolution, underscoring the functional importance of these residues.
|
| Functional studies
|
No functional studies were performed for this variant.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
|
p.283Y>D
|
Ebstein's malformation of tricuspid valve
|
PMID:21127202
|
Ebstein, ASD type II, LVNC (kindred 110.647)
|
Dominant Familial
|
 show  hide
| Genetic evidence
|
Segregating : Family screening identified LVNC in a five family members. In addition, one family member presented with Ebstein's anomaly, and one with a perimembranous VSD. All affected family members carried the mutation. This variant was not found in 490 ethnically matched controls.
|
| in silico prediction
|
All identified missense mutations affect amino acids with high degrees of conservation throughout evolution, underscoring the functional importance of these residues.
|
| Functional studies
|
No functional studies were performed for this variant.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
|
p.350Y>D
|
Ebstein's malformation of tricuspid valve
|
PMID:21127202
|
Ebstein, biventricular non-compaction (proband DB)
|
Recessive Familial
|
 show  hide
| Genetic evidence
|
Segregating This variant was not found in 490 ethnically matched controls.
|
| in silico prediction
|
All identified missense mutations affect amino acids with high degrees of conservation throughout evolution, underscoring the functional importance of these residues.
|
| Functional studies
|
No functional studies were performed for this variant.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
|
p.390L>P
|
Ebstein's malformation of tricuspid valve
|
PMID:21127202
|
Ebstein, LVNC (proband BT)
|
Dominant Sporadic
|
 show  hide
| Genetic evidence
|
This variant was inherited from an unaffected parent. This variant was not found in 490 ethnically matched controls.
|
| in silico prediction
|
All identified missense mutations affect amino acids with high degrees of conservation throughout evolution, underscoring the functional importance of these residues.
|
| Functional studies
|
No functional studies were performed for this variant.
|
| Comments
|
Further functional studies are required to assess the impact of this variant on cardiac development.
|
|
Representation of protein MYH7

Heart expression domain of MYH7
No specified expression domain for MYH7
Add a new domain where gene MYH7 is expressed
Associated CHDs found by automated text mining
See complete results on Genopedia (including non CHD)
Heart defects
This page contributors
- Jeroen Breckpot - CME Leuven (Belgium) (association, mutation, study, Free text)